Money for drug watchdog27th June 2008
The chairman of the National Institute for Health and Clinical Excellence (NICE) has told the BBC he thinks the organisation will receive more funding.
NICE decides which drugs can be offered and how patients are treated by the NHS in England, Wales and Northern Ireland.
Sir Michael Rawlins spoke to the BBC as a way of marking the 60th anniversary of the health service.
He said that by 2010 NICE will have finished 120 guidelines and they would need to revise them "every three or four years" to keep them relevant.
He added: "So we are proposing to the government that they invest much more heavily in our guidelines programme, so we can do a whole lot of further guidelines."
"This will mean we can considerably improve the quality of care patients get from the NHS."
The most recent controversy linked to NICE has been the "co-payments" issue, where a patient who receives private care is then refused health service treatment.
The issue is subject to a ministerial review in Scotland, Wales and England.
Sir Michael said the topic was one which needed to be discussed openly and that it was a complex issue.
"It is a political decision that parliament should decide, on behalf of people who use and pay for the NHS," he said.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Money for drug watchdog
Author: Jess Laurence
Article Id: 7305
Date Added: 27th Jun 2008